Sidney X. Liang | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Sidney X. Liang is active.

Explore More

Publication

Featured researches published by Sidney X. Liang.

Bioorganic & Medicinal Chemistry Letters | 2007

PDE-10A inhibitors as insulin secretagogues

Louis-David Cantin; Steven Magnuson; David E. Gunn; Nicole Barucci; Marina Breuhaus; William Bullock; Jennifer Burke; Thomas Claus; Michelle Daly; Lynn B. DeCarr; Ann Gore-Willse; Helana Hoover-Litty; Ellalahewage Kumarasinghe; Yaxin Li; Sidney X. Liang; James N. Livingston; Timothy B. Lowinger; Margit MacDougall; Herbert Ogutu; Alan Olague; Ronda Ott-Morgan; Robert W. Schoenleber; Adrian Tersteegen; Philip Wickens; Zhonghua Zhang; Jian Zhu; Lei Zhu; Laurel Sweet

Archive | 2004

1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders

Yamin Wang; William Bullock; David E. Gunn; Qingjie Liu; Sidney X. Liang; Donglei Liu; Steven Magnuson; Tindy Li; Eric S. Mull; Jill E. Wood; Ning Qi

Archive | 2003

Anilinopyrazole derivatives useful for the treatment of diabetes

Joachim Rudolph; Louis-David Cantin; Steven Magnuson; William Bullock; Ann-Marie Bullion; Libing Chen; Chih-Yuan Chuang; Sidney X. Liang; Dyuti Majumdar; Herbert Ogutu; Alan Olague; Ning Qi; Philip Wickens

Archive | 2002

1, 8-naphthyridine derivatives as antidiabetics

Yamin Wang; David E. Gunn; Qingjie Liu; Sidney X. Liang; William Bullock; Donglei Liu; Steven Magnuson; Tindy Li; Eric S. Mull; Jill E. Wood; Ning Qi

Archive | 2003

Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics

Philip Wickens; Louis-David Cantin; Chih-Yuan Chuang; Miao Dai; Martin F. Hentemann; Ellalahewage Kumarasinghe; Sidney X. Liang; Derek Lowe; Tatiana Shelekhin; Yamin Wang; Chengzhi Zhang; Hai-Jun Zhang; Qian Zhao

Archive | 2003

Indane acetic acid derivatives and their use as pharmaceutical agents

Philip Wickens; Louis-David Cantin; Ellalahewage Kumarasinghe; Chih-Yuan Chuang; Sidney X. Liang

Bioorganic & Medicinal Chemistry Letters | 2007

Indanylacetic acids as PPAR-δ activator insulin sensitizers

Philip Wickens; Chengzhi Zhang; Xin Ma; Qian Zhao; John Amatruda; William Bullock; Michael Burns; Louis-David Cantin; Chih-Yuan Chuang; Thomas Claus; Miao Dai; Fernando E. Dela Cruz; David Dickson; Frederick J. Ehrgott; Dongping Fan; Sarah Heald; Martin F. Hentemann; Christiana Iwuagwu; Jeffrey S Johnson; Ellalahewage Kumarasinghe; David Ladner; Rico C. Lavoie; Sidney X. Liang; James N. Livingston; Derek Lowe; Steve Magnuson; Gretchen Mannelly; Ingo A. Mugge; Herbert Ogutu; ‡ Susan Pleasic-Williams

Archive | 2005

Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes

David Cantin; Steven Magnuson; David Gunn; William H. Bullock; Jennifer Burke; Wenlang Fu; Ellalahewage Kumarasinghe; Sidney X. Liang; Jason Newcom; Herbert Ogutu; Philip Wickens; Zhonghua Zhang; Donald Bierer

Archive | 2005

5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes

Louis-David Cantin; Xin Ma; Christiana Akuche; Sidney X. Liang

Bioorganic & Medicinal Chemistry Letters | 2007

Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists

Louis-David Cantin; Sidney X. Liang; Herbert Ogutu; Christiana Iwuagwu; Ken Boakye; William Bullock; Michael Burns; Roger Clark; Thomas Claus; Fernando E. delaCruz; Michelle Daly; Frederick J. Ehrgott; Jeffrey S Johnson; Christine Keiper; James N. Livingston; Robert W. Schoenleber; Jeffrey Shapiro; Christopher Town; Ling Yang; Manami Tsutsumi; Xin Ma

Explore More